These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16845707)

  • 1. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG; Gehlbach SH; Curtis JR; Youket TE; Worley K; Lange JL
    J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
    Mudano A; Allison J; Hill J; Rothermel T; Saag K
    J Rheumatol; 2001 Jun; 28(6):1298-305. PubMed ID: 11409123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
    Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.
    Coulson KA; Reed G; Gilliam BE; Kremer JM; Pepmueller PH
    J Clin Rheumatol; 2009 Jun; 15(4):155-60. PubMed ID: 19363452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C; Vij AS
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
    Feldstein AC; Elmer PJ; Nichols GA; Herson M
    Osteoporos Int; 2005 Dec; 16(12):2168-74. PubMed ID: 16142501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
    Ettinger B; Chidambaran P; Pressman A
    Am J Manag Care; 2001 Jun; 7(6):597-605. PubMed ID: 11439733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In whom and how to prevent glucocorticoid-induced osteoporosis.
    Adachi JD; Papaioannou A
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan.
    Chitre MM; Hayes W
    J Manag Care Pharm; 2008 Apr; 14(3):281-90. PubMed ID: 18439050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability to follow anti-reabsorptive drug treatment in postmenopausal women with reduced bone mass.
    Gomes DC; Costa-Paiva L; Farhat FC; Pedro AO; Pinto-Neto AM
    Menopause; 2011 May; 18(5):531-6. PubMed ID: 21242816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
    Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
    J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.